Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine (NCT05373030) | Zhejiang Provincial Center for Disease Control and Prevention | 2022-05-14 |
Track Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization automatically
Every clearance here is in the API, with alerts when new ones post.